Last week, we wrote a post on new analytical methods for the detection of impurities that our R&D group had developed for the drug Febuxostat. And we’ve done the same…
In this month’s issue of PharmTech, team members at Neuland’s R&D Center in Hyderabad published a peer-reviewed article on the analysis and management of impurities in the drug Febuxostat. Febuxostat, a…
I hope everyone had a great summer! We’ve certainly kept busy. We started July with our rebranding, and spent the summer manufacturing plenty of APIs, drugs and peptides. And while…